SCHEMBL8957334

SCHEMBL8957334

CC(C)(C)c1ccc(C(OCCO[N+](=O)[O-])c2ccc(Cl)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.40
LMNA P02545 3/20 0.37
KCNH2 Q12809 3/20 0.37
HRH1 P35367 2/20 0.37
NR1I2 O75469 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
CNR1 P21554 1/20 0.37
OPRK1 P41145 1/20 0.37
PDE4D Q08499 1/20 0.37
GHSR Q92847 1/20 0.37
UTS2R Q9UKP6 2/20 0.37
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP3A4 P08684 2/20 0.35
CHRM2 P08172 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9874449 0.74 PTGS1 (0.49) PTGS2LMNAKCNH2HRH1OPRK1
SCHEMBL4667552 0.72 IDO1 (0.54) LMNAKCNH2HRH1POLBSMN1; SMN2
SCHEMBL8957482 0.71 GRIA4 (0.40) PTGS2LMNACNR1SMN1; SMN2TSHR
SCHEMBL8957402 0.69 GRIN2D (0.49) PTGS2LMNAPOLBCYP1A2CYP2C19
SCHEMBL14160199 0.68 LMNA (0.49) LMNAKCNH2HRH1POLBSMN1; SMN2
SCHEMBL4669314 0.66 CYP3A4 (0.64) LMNAKCNH2HRH1OPRK1SMN1; SMN2
SCHEMBL5190981 0.66 CYP3A4 (0.64) LMNAKCNH2HRH1OPRK1SMN1; SMN2
SCHEMBL423397 0.66 LMNA (0.54) LMNAKCNH2HRH1POLBSMN1; SMN2
SCHEMBL15929169 0.66 MAPT (0.47) LMNASMN1; SMN2TSHRMEN1KMT2A
SCHEMBL197202 0.65 MEN1 (0.62) LMNAHRH1CNR1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed